July 12, 2022 11:13 AM EDT
News Briefing

Con­nect shrinks time­line for atopic der­mati­tis da­ta; Bi­cy­cle's wheels keep turn­ing with Genen­tech

Kyle LaHucik

Senior Reporter

Tyler Patchen

News Reporter

Con­nect Bio­phar­ma has pushed up the time­line on re­leas­ing topline da­ta for its lead can­di­date, be­ing test­ed in Chi­na, for atopic …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Up­com­ing PDU­FA dates may be en­snared by Trump's pause at HHS, an­a­lyst says

With Sam Alt­man’s help, Retro Bio­sciences eyes $1B to ex­tend lifes­pan by 10 years

Mer­ck and Ei­sai re­veal late-stage fail for Keytru­da and Lenvi­ma in gas­troe­sophageal can­cer

The cru­cial obe­si­ty da­ta to watch for this year

No­vo Nordisk’s amy­cretin prompts 22% weight loss in ear­ly obe­si­ty tri­al

sponsored

Fu­el­ing More Break­throughs: Man­u­fac­tur­ing In­no­va­tion to Ex­pand Gene Ther­a­py’s Reach

A service from the Financial Times